Business & EconomyHealth
Moderna Stock Nearly Triples on Cancer Vaccine Trial
Moderna shares surged 177% after its personalized mRNA cancer vaccine met Phase 3 endpoints in melanoma, marking a historic milestone for cancer treatment.
—6 min read
Tag
#Cancer Vaccine
4 articles
HealthMedical Research
Pancreatic Cancer Vaccine Shows Promise in First Human Trial
A Johns Hopkins vaccine targeting KRAS mutations safely triggered immune responses in 90% of participants, a breakthrough in pancreatic cancer prevention.
—4 min read
HealthMedical Research
mRNA Cancer Vaccine Slashes Melanoma Recurrence by 49%
Moderna and Merck's mRNA vaccine reduced melanoma recurrence risk by 49% over five years, offering new hope for advanced skin cancer patients.
—4 min read
HealthMedical Research
mRNA Vaccine Shows Lasting Protection Against Melanoma
A personalized mRNA cancer vaccine combined with Keytruda reduced melanoma recurrence risk by 49% over five years, according to new clinical trial data.
—4 min read